Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.

Détails

Ressource 1Télécharger: serval:BIB_0FA69685624F.P001 (100.27 [Ko])
Etat: Public
Version: de l'auteur
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_0FA69685624F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Périodique
The Journal of Antimicrobial Chemotherapy
Auteur(s)
Posteraro B., Sanguinetti M., Fiori B., La Sorda M., Spanu T., Sanglard D., Fadda G.
ISSN
0305-7453
Statut éditorial
Publié
Date de publication
08/2006
Peer-reviewed
Oui
Volume
58
Numéro
2
Pages
458-461
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Résumé
OBJECTIVES: Several studies have documented the potent in vitro activity of caspofungin against Candida spp. This is of special concern for Candida glabrata infections that are often resistant to many azole antifungal agents and, consequently, difficult to treat. The aim of the present study was to expand the data on the in vitro activity of caspofungin against azole-resistant isolates of C. glabrata. METHODS: A total of 50 clinical isolates of C. glabrata were tested for susceptibility to caspofungin. The isolates were cross-resistant to multiple azoles, including fluconazole, itraconazole, ketoconazole and voriconazole. Expression of the resistance-related CgCDR1 and CgCDR2 genes was evaluated by quantitative RT-PCR analysis. The MICs of caspofungin were determined by using the National Committee for Clinical Laboratory Standards M27-A2 reference method. RESULTS: C. glabrata isolates exhibited increased expression of the CDR efflux pump(s), and this was in accordance with their high-level azole resistance. In contrast, all the isolates were highly susceptible to caspofungin (100% of isolates were inhibited at <or=1 mg/L). CONCLUSIONS: Our results represent further evidence for the excellent antifungal potency of caspofungin, particularly against C. glabrata isolates expressing cross-resistance to azoles.
Mots-clé
Antifungal Agents/pharmacology, Azoles/pharmacology, Biological Transport, Active/genetics, Candida glabrata/drug effects, Candida glabrata/genetics, Drug Resistance, Fungal/genetics, Echinocandins, Gene Expression, Humans, Microbial Sensitivity Tests, Peptides, Cyclic/pharmacology, RNA, Fungal/analysis, Reverse Transcriptase Polymerase Chain Reaction
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/01/2008 14:40
Dernière modification de la notice
25/09/2019 6:08
Données d'usage